Skip to Main Content

Paper Details

Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease.
Clin Trials
0
2019
Author NameAffiliation
Krista K Vermillion6 Johns Hopkins University School of Medicine
Harold P LehmannJohns Hopkins University School of Medicine
  • 1 - 2

Datasets

Release 1.2